Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Juan Ramon Navarro-Cabrera"'
Autor:
Raymond Siu Ming Wong, Juan Ramon Navarro-Cabrera, Narcisa Sonia Comia, Yeow Tee Goh, Henry Idrobo, Daolada Kongkabpan, David Gómez-Almaguer, Mohammed Al-Adhami, Temitayo Ajayi, Paulo Alvarenga, Jessica Savage, Pascal Deschatelets, Cedric Francois, Federico Grossi, Teresita Dumagay
Publikováno v:
Blood Advances. 7:2468-2478
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disease characterized by complement-mediated hemolysis. Pegcetacoplan is the first C3-targeted therapy approved for adults with PNH (United States), adults with PNH with inadequate response or intol
Autor:
Angelo Maiolino, Jose Luis Lopez Dopico, Juan Ramon Navarro Cabrera, Guilhermo e Quintero Vega, Vania Hungria, Jean-Luc Harousseau, Lidiane Andino Neves, Douglas Rosales Ortiz, Jose Willian Oliveros Alvear, Willen Bujan, Roberto Jose Pessoa de Magalhaes Filho, Edvan de Queiroz Crusoe, Brian G.M. Durie, Guilhermo Conte, Jose Macias, Mercedes Royg, Dorotea Fantl, German Espino, Zurelis Socarra, Diana Katerine Garcia, Guillermo J. Ruiz-Argüelles, Eloisa Riva
Publikováno v:
Clinical lymphoma, myelomaleukemia. 19(1)
Introduction Latin American countries (LATAMC) represent a large fraction of patients treated for multiple myeloma (MM) worldwide. In order to understand the difficulty of access to anti-myeloma therapy in LATAMC, we designed this study that explores
Autor:
Angelo Maiolino, Zurelis Socarra, Mercedes Royg, Diana Katerine Garcia, Vania Hungria, Willen Bujan, Guilhermo Ruiz Arguelles, Brian G.M. Durie, Guilhermo Conte, Lidiane Andino Neves, Jose Luis Lopez Dopico, Edvan de Queiroz Crusoe, Dorotea Fantl, Juan Ramon Navarro Cabrera, Guilhermo e Quintero Vega, German Espino, Jorge Willian Oliveros Alvear, Jose Macias, Eloisa Riva, Roberto Jose Pessoa de Magalhaes Filho, Douglas Rosales Ortiz
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:e15-e16
Autor:
David Gómez-Almaguer, Juan Ramon Navarro Cabrera, Virginia Abello Polo, Adriana Bustinza, Nancy Labastida Mercado, Samanta Becerra Galindo, Licet Villamizar Gómez, José Carlos Jaime Pérez, Cesar Homero Gutierrez Aguirre, Enrique Pedraza Mesa, Guillermo J. Ruiz-Argüelles, Alberto Vazquez-Mellado
Publikováno v:
Blood. 124:1255-1255
Severe aplastic anemia (SAA) is characterized by the absence of progenitor hematopoietic cells in bone marrow caused mainly by autoimmunity. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the treatment of choice for young newly dia